Literature DB >> 20112525

It is possible to perform a double-blind hyperbaric session: a double-blinded randomized trial performed on healthy volunteers.

T Jansen1, C R Mortensen, M F Tvede.   

Abstract

In hyperbaric medicine, blinded trials are remarkably few, making results susceptible to criticism. The scopes of the present study are to present a method for a double-blinded randomized clinical study and evaluate the validity of the method in a hyperbaric setting. Twenty-two healthy volunteers with no diving experience were included. The volunteers were randomized either to a "therapeutic pressure" group (15 msw, 253 kPa) or to a "placebo" group (2 msw, 120 kPa). The two profiles were made equal regarding noise, temperature and ventilation. The volunteers were asked whether they had been exposed to placebo or therapeutic pressure. They were asked to present their certainness of the answer on a visual analogue scale (VAS). Fisher's exact test calculates a probability of P = 0,328, which indicates that the volunteers have no valid opinion as to whether they were exposed to 15 msw or to 2 msw. It is found that it is possible to perform a blinded treatment on healthy volunteers with no prior diving experience.

Mesh:

Year:  2009        PMID: 20112525

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  2 in total

1.  A single session of hyperbaric oxygen therapy demonstrates acute and long-lasting neuroplasticity effects in humans: a replicated, randomized controlled clinical trial.

Authors:  Anna M Wahl; Daniel Bidstrup; Isabel G Smidt-Nielsen; Mads U Werner; Ole Hyldegaard; Per Rotbøll-Nielsen
Journal:  J Pain Res       Date:  2019-07-31       Impact factor: 3.133

Review 2.  Double-blind trials in hyperbaric medicine: A narrative review on past experiences and considerations in designing sham hyperbaric treatment.

Authors:  C A Lansdorp; Rob A van Hulst
Journal:  Clin Trials       Date:  2018-06-04       Impact factor: 2.486

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.